Revolution Medicines stock forecast
Revolution Medicines (42Z) Stock Forecast & Price Target
42Z Analyst Ratings
42Z Stock 12 Month Forecast
Average Price Target
€245.62▲(67.94% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Robert Burns | H.C. Wainwright | €318.34 | buy | 117.67%Upside | Reiterated | 11/17/26 | ||
| Sean Laaman | Morgan Stanley | €247.40→€224.66 | buy | 53.61%Upside | Reiterated | 11/13/26 | ||
| Alec Stranahan | Bank of America Securities | €249.22 | buy | 70.40%Upside | Reiterated | 11/12/26 | ||
| Laura Prendergast | Stifel Nicolaus | €209.20 | buy | 43.04%Upside | Reiterated | 11/09/26 | ||
| Brian Cheng | J.P. Morgan | €223.75→€262.86 | buy | 79.73%Upside | Reiterated | 11/09/26 | ||
| Kelsey Goodwin | Piper Sandler | €191.01→€201.92 | buy | 38.06%Upside | Reiterated | 11/05/26 | ||
| Leonid Timashev | RBC Capital | €236.48→€291.97 | buy | 99.63%Upside | Assigned | 11/05/26 | ||
| Robert Driscoll | Wedbush | €204.65 | buy | 39.93%Upside | Reiterated | 11/05/26 | ||
| Jay Olson | Oppenheimer | €236.48 | buy | 61.70%Upside | Reiterated | 11/05/26 | ||
| Cory Kasimov | Evercore ISI | €291.06→€309.25 | buy | 111.45%Upside | Reiterated | 11/05/26 | ||
| Tyler Van Buren | TD Cowen | €227.39→€245.58 | buy | 67.92%Upside | Assigned | 11/05/26 | ||
| Leerink Partners | €261.95→€282.87 | buy | 93.42%Upside | Reiterated | 11/05/26 | |||
| Jeffrey Walch | Bernstein | €162.81 | hold | 11.32%Upside | Reiterated | 11/04/26 | ||
| Michael Schmidt | Guggenheim | €250.13→€271.05 | buy | 85.33%Upside | Reiterated | 11/04/26 | ||
| Michael Yee | UBS | €241.03 | buy | 64.81%Upside | Assigned | 10/22/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Robert BurnsH.C. Wainwright | BuyReiterated€318.34 | 11/17/26 | 117.67%Upside | ||
| Sean LaamanMorgan Stanley | BuyReiterated€247.40→€224.66 | 11/13/26 | 53.61%Upside | ||
| Alec StranahanBank of America Securities | BuyReiterated€249.22 | 11/12/26 | 70.40%Upside | ||
| Laura PrendergastStifel Nicolaus | BuyReiterated€209.20 | 11/09/26 | 43.04%Upside | ||
| Brian ChengJ.P. Morgan | BuyReiterated€223.75→€262.86 | 11/09/26 | 79.73%Upside | ||
| Kelsey GoodwinPiper Sandler | BuyReiterated€191.01→€201.92 | 11/05/26 | 38.06%Upside | ||
| Leonid TimashevRBC Capital | BuyAssigned€236.48→€291.97 | 11/05/26 | 99.63%Upside | ||
| Robert DriscollWedbush | BuyReiterated€204.65 | 11/05/26 | 39.93%Upside | ||
| Jay OlsonOppenheimer | BuyReiterated€236.48 | 11/05/26 | 61.70%Upside | ||
| Cory KasimovEvercore ISI | BuyReiterated€291.06→€309.25 | 11/05/26 | 111.45%Upside | ||
| Tyler Van BurenTD Cowen | BuyAssigned€227.39→€245.58 | 11/05/26 | 67.92%Upside | ||
| BuyReiterated€261.95→€282.87 | 11/05/26 | 93.42%Upside | |||
| Jeffrey WalchBernstein | HoldReiterated€162.81 | 11/04/26 | 11.32%Upside | ||
| Michael SchmidtGuggenheim | BuyReiterated€250.13→€271.05 | 11/04/26 | 85.33%Upside | ||
| Michael YeeUBS | BuyAssigned€241.03 | 10/22/26 | 64.81%Upside |
Best Analysts Covering Revolution Medicines
Copying Charles Zhu's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +38.64% per trade.
Copying Michael Schmidt's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +79.86% per trade.
Copying Ami Fadia's trades and holding each position for 2 Years would result in 92.86% of your transactions generating a profit, with an average return of +180.63% per trade.
42Z Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 5 | 6 | 13 |
| Buy | 50 | 74 | 59 | 64 | 37 |
| Hold | 3 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 59 | 81 | 68 | 74 | 53 |
In the current month, 42Z has received 50 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 42Z average Analyst price target in the past 3 months is 245.62.
42Z Financial Forecast
42Z Earnings Forecast
Next quarter’s earnings estimate for 42Z is -EUR 1.06 with a range of -EUR 2.22 to EUR 0.00. The previous quarter’s EPS was -EUR 1.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
42Z Sales Forecast
Next quarter’s sales forecast for 42Z is EUR 367.41M with a range of EUR 163.36M to EUR 577.56M. The previous quarter’s sales results were EUR 179.69M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

